ncRNA name
MIR155HG
Specific or universal ncRNAs
Specific ncRNAs
Class
Long noncoding RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
PTBP1
Cancer name
Glioma
Cancer site
None
Treatment type
Chemotherapy
Drug
Temozolomide
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
LncRNA MIR155HG Promotes Temozolomide Resistance by Activating the Wnt/Ī²-Catenin Pathway Via Binding to PTBP1 in Glioma
Tissue resource
Experiment
None
Institute
Country
Continent